Repligen Executive and Leadership Team

Olivier Loeillot, the Chief Executive Officer at Repligen, directs the company's overarching strategy and operational execution. Loeillot guides Repligen's mission to inspire advances in bioprocessing, focusing on the development and commercialization of high-value products. This leadership role involves ensuring that the company's flexible solutions effectively address critical steps in the production of biologic drugs. By setting the strategic vision, Olivier Loeillot drives the company's market position and growth within the life sciences sector. The Chief Executive Officer ensures alignment across all departments, fostering an environment of innovation and efficiency to meet the evolving needs of biopharmaceutical manufacturing. Loeillot's leadership is central to advancing Repligen's commitment to quality and customer success in a dynamic global market.

Jason Garland, the Chief Financial Officer at Repligen, manages the company's financial operations and strategic fiscal planning. Garland oversees all aspects of financial reporting, budgeting, and capital allocation, ensuring the economic health and sustainability of Repligen's bioprocessing solutions. This critical role involves driving financial performance and supporting the commercialization of high-value products that address key steps in biologic drug production. By guiding financial strategy, Jason Garland enables the company to invest in innovation and expand its market reach. The Chief Financial Officer is instrumental in maintaining investor confidence and securing resources for future growth. Garland's expertise ensures that Repligen operates with financial discipline and strategic foresight in the competitive life sciences landscape.

Min Sheu, the Chief Operating Officer at Repligen, directs the company's operational efficiency and manufacturing excellence. Sheu oversees the development and scaling of high-value products and flexible solutions that are critical for the production of biologic drugs. This leadership function ensures that Repligen's operations effectively support its mission to advance bioprocessing. By optimizing supply chains and manufacturing processes, Min Sheu enhances product delivery and customer satisfaction. The Chief Operating Officer is responsible for driving operational improvements that align with the company's strategic goals and market demands. Sheu's focus on operational rigor underpins Repligen's ability to consistently deliver quality solutions to the biopharmaceutical industry, reinforcing the company's commitment to innovation and reliability.

Keith Lee Lee Robinson, the Chief Information Officer at Repligen, architects the company's technology infrastructure and digital strategy. Robinson oversees the implementation of robust IT systems that support Repligen's bioprocessing solutions and critical manufacturing steps. This leadership position ensures data integrity, cybersecurity, and the seamless flow of information across the organization, directly impacting the efficiency of biologic drug production. By driving technological innovation, Keith Lee Lee Robinson enhances operational capabilities and supports the company's growth objectives. The Chief Information Officer is responsible for leveraging digital tools to optimize business processes and maintain a competitive edge in the life sciences industry. Robinson's focus remains on building scalable and secure technology platforms that empower Repligen's mission.